Whalen Wealth Management Inc. Buys 4,709 Shares of Danaher Corporation $DHR

Key Points

• Whalen Wealth Management initiated a Danaher position by purchasing 4,709 shares valued at approximately $1.04 million. Institutional investors and hedge funds collectively own 79.05% of Danaher’s outstanding shares.
• Analysts maintain a generally positive outlook, with Danaher holding a “Moderate Buy” consensus rating and an average price target of $235.23; recent targets range from $195 to $255.
• Danaher exceeded quarterly expectations with adjusted earnings of $1.94 per share and revenue of $6.26 billion, while declaring a quarterly dividend of $0.40 per share, equivalent to a 0.7% annual yield.

Whalen Wealth Management Inc. bought a new stake in Danaher Corporation (NYSE:DHR - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 4,709 shares of the conglomerate's stock, valued at approximately $1,043,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vann Equity Management LLC acquired a new position in shares of Danaher in the 3rd quarter valued at $1,911,000. Chickasaw Capital Management LLC acquired a new stake in Danaher during the 3rd quarter worth $576,000. Veery Capital LLC grew its position in Danaher by 3.1% during the 3rd quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate's stock worth $350,000 after purchasing an additional 48 shares during the last quarter. Venture Visionary Partners LLC increased its stake in Danaher by 181.4% in the third quarter. Venture Visionary Partners LLC now owns 26,039 shares of the conglomerate's stock valued at $5,769,000 after purchasing an additional 16,784 shares during the period. Finally, Elevation Wealth Partners LLC increased its stake in Danaher by 91.2% in the third quarter. Elevation Wealth Partners LLC now owns 887 shares of the conglomerate's stock valued at $197,000 after purchasing an additional 423 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Wells Fargo & Company decreased their target price on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 22nd. Barclays boosted their price target on Danaher from $230.00 to $255.00 and gave the company an "overweight" rating in a research report on Wednesday. The Goldman Sachs Group increased their price objective on Danaher from $210.00 to $250.00 and gave the stock a "buy" rating in a research report on Monday, September 21st. TD Cowen lowered their target price on Danaher from $240.00 to $236.00 and set a "buy" rating on the stock in a research note on Wednesday, July 22nd. Finally, Royal Bank Of Canada boosted their target price on Danaher from $215.00 to $250.00 and gave the company an "outperform" rating in a report on Monday. Two analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Danaher presently has a consensus rating of "Moderate Buy" and an average target price of $235.23.

Danaher Stock Performance

NYSE DHR traded down $4.16 during trading hours on Thursday, hitting $214.33. 2,379,154 shares of the stock were exchanged, compared to its average volume of 4,448,717. The company has a market cap of $150.67 billion, a price-to-earnings ratio of 38.05, a price-to-earnings-growth ratio of 2.68 and a beta of 0.76. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The stock has a 50-day moving average of $210.46 and a 200 day moving average of $194.25. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter last year, the firm earned $0.77 earnings per share. The firm's revenue was up 5.5% compared to the same quarter last year. As a group, equities research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.40 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher's payout ratio is 28.42%.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.